Normal view MARC view ISBD view

Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.

Matos, Ignacio

Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer. [electronic resource] - Expert opinion on emerging drugs Sep 2016 - 267-82 p. digital

Publication Type: Journal Article; Review

ISSN: 1744-7623

Standard No.: 10.1080/14728214.2016.1220535 doi

Subjects--Topical Terms:
Antineoplastic Agents--adverse effects
Colorectal Neoplasms--drug therapy
Drug Resistance, Neoplasm
Humans
Molecular Targeted Therapy
Neoplasm Metastasis
Protein Kinase Inhibitors--adverse effects
Protein-Tyrosine Kinases--antagonists & inhibitors
Survival Rate

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)